Insurance coverage for GLP-1 drugs remains tight despite rising demand, with more patients facing restrictions or paying out ...
section. Victoza contains the active ingredient liraglutide. It belongs to a group of diabetes drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Victoza is a brand-name medication ...
Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.
10d
News Medical on MSNStudy shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetesKidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.
China represents an untapped market for GLP-1 class diabetes drugs, according to Novo Nordisk, which is predicting "good momentum" for its already-approved Victoza, and its successor semaglutide.
Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce inflammation and improve heart health. With such advantages, the demand ...
Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...
THURSDAY, March 6, 2025 (HealthDay News) -- GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study suggests. The drugs help manage patients ...
Kidney transplant patients prescribed GLP-1 drugs were 49% less likely to experience organ failure, in which their new kidney stops working and they have to resume dialysis, researchers reported ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results